An editorial discussing the necessity of randomized controlled trials in the context of heart failure with preserved ejection fraction, referencing the PARAMOUNT and PARADIGM-HF trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
O’Connor et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: